The full cost includes the visit, the blood work, and later care

Insurance may say no even after a helpful phone call

Medicare covers PRP only for certain long-lasting wounds. It doesn't broadly pay for PRP used near joints or tendons. Other health plans may also leave you with the whole bill. Call the plan first, then check the clinic price.

Ask the clinic for its billing codes, the short labels it sends with a claim. You'll give those labels to the plan and ask what it may pay. Include the exam, ultrasound pictures used during care, and later checks. A yes by phone still won't promise payment after the claim arrives.

A written total keeps the price easy to compare

The quote needs the blood draw, preparation, each planned visit, and follow-up. It can't leave out any added cost for ultrasound pictures. Ask about a fee if you cancel or the exam changes the choice. A monthly payment won't show the full amount owed.

Compare that amount with care your plan may cover. Exercise, a brace, or medicine may still have a place. Don't stop useful home care while you're waiting for answers. Ask how long the doctor or nurse would wait before judging any change. QC Kinetix offers a consultation and regenerative treatments, meaning non-surgical care based on blood drawn and processed at the clinic, through medical providers who'll examine the sore area and review your health during the visit.

Sources

1. Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.

   Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.

2. The devices used to spin PRP at the point of care are cleared by FDA as clinical centrifuges, product code JQC, a Class I device under 21 CFR 862.2050 - for example the Biomet GPS Platelet Separation Kit (K030555, cleared 2003) and the Harvest SmartPrep2 / SmartPrep Platelet Concentration System (K103340, cleared 2010). That clearance covers the equipment that separates blood. It is not an FDA approval of platelet-rich plasma as a treatment for osteoarthritis, tendinopathy or any other orthopedic condition, and copy must never blur the two.

   U.S. Food and Drug Administration (Center for Devices and Radiological Health) — 510(k) Premarket Notification database and Product Classification: JQC, Centrifuges (Micro, Ultra, Refrigerated) For Clinical Use, 21 CFR 862.2050. FDA accessdata (CDRH device databases), 2003.

3. In January 2025 the FTC and the Georgia Attorney General obtained federal court orders permanently BANNING the co-founders of the Stem Cell Institute of America and related companies from marketing stem cell therapy, plus $5,155,146 in civil penalties and consumer refunds. The court found on summary judgment that the defendants published false and misleading advertisements about the efficacy and approval of stem cell injections for conditions including osteoarthritis; the affiliated clinic had charged up to $5,000 per injection, almost exclusively to elderly and disabled consumers.

   Federal Trade Commission — Stem Cell Institute Co-Founders and Companies Banned from Marketing Stem Cell Treatments and Ordered to Pay More Than $5.1 Million for Refunds and Civil Penalties. FTC Press Release, 2025.

4. A web surveillance study of regenerative medicine clinics in the US-Mexico border region found 99.1% of the clinic websites mentioned no affiliation with an academic institution or other overt token of scientific legitimacy, 67.3% claimed autologous tissue as the source of treatment, and most did not specify the route of administration. Of the Tijuana clinics identified, 13 claimed licensing but only one matched available licensing records.

   Chavez J, Shah NA, Ruoss S, et al. — Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study. Stem Cell Research & Therapy, 2021. DOI: 10.1186/s13287-021-02254-4.

5. The 2019 ACR/Arthritis Foundation osteoarthritis guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-management programmes, tai chi, cane use, tibiofemoral bracing, topical and oral NSAIDs and intra-articular glucocorticoid injections for knee OA. Its conditional recommendations cover balance exercises, yoga, CBT, acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol. Anything offered before a course of the strongly recommended options is being offered out of order.

   Kolasinski SL, Neogi T, Hochberg MC, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41142.

6. The Cochrane review of exercise for knee osteoarthritis found low- to moderate-certainty evidence that exercise probably improves pain, physical function and quality of life in the short term - but when the results were compared against established minimal important difference thresholds (12 points for pain, 13 for function, 15 for quality of life on 0-100 scales), the confidence intervals either did not reach those thresholds or spanned both important and unimportant improvement. Honest copy about exercise carries the same caveat honest copy about PRP does.

   Lawford BJ, Hall M, Hinman RS, et al. — Exercise for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2024. DOI: 10.1002/14651858.CD004376.pub4.